United Guardian (UG) Dividend Coverage Ratio Growth (1y) (2011 - 2026)
Powered by 
Analysis
United Guardian (UG) Dividend Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.84 Bn | 623.08 Bn | 17.26 Bn | -3.09% |
| 2 | AbbVie | 441.33 Bn | 434.76 Bn | 12.70 Bn | 264.24% |
| 3 | Merck | 364.84 Bn | 357.70 Bn | 12.21 Bn | -129.25% |
| 4 | Novartis Ag | 266.34 Bn | 258.65 Bn | 11.24 Bn | -30.09% |
| 5 | Pfizer | 159.07 Bn | 147.37 Bn | 10.94 Bn | -108.11% |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn | -92.21% |
| 7 | Revolution Medicines | 44.22 Bn | 44.22 Bn | - | - |
| 8 | Incyte | 25.24 Bn | 20.70 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.42 Bn | 18.76 Bn | 683.80 Mn | - |
| 10 | United Guardian | 32.67 Mn | 23.07 Mn | 1.55 Mn | 653.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 653.55% |
| Mar 31, 2026 | 104.39% |
| Sep 30, 2025 | -69.77% |
| Mar 31, 2025 | -56.71% |
| Sep 30, 2024 | -63.68% |
| Dec 31, 2022 | 50.81% |
| Jun 30, 2022 | 151,345.41% |
| Dec 31, 2021 | 9.45% |
| Jun 30, 2021 | 16.64% |
| Dec 31, 2020 | -42.48% |
| Jun 30, 2020 | 29.07% |
| Dec 31, 2019 | 151.75% |
| Dec 31, 2018 | 21.93% |
| Dec 31, 2017 | -45.05% |
| Dec 31, 2016 | 312.95% |
| Dec 31, 2015 | -89.76% |
| Dec 31, 2014 | 5.21% |
| Dec 31, 2013 | 687.88% |
| Dec 31, 2012 | -132.99% |
| Dec 31, 2011 | -30.48% |